Clinical signs become apparent at 5–6 months of age. These clinical signs include ataxia (incoordination), intention tremor (a tremor that is evident when an affected dog initiates a voluntary movement), dysmetria (disturbance in the control in the range of muscular movement), progressive inability to stand, corneal clouding, and muscle rigidity. Dogs with this disease have dramatically shortened life expectancies and generally live for 14–15 months.
Fluorescence microscopy of unstained neurons of the cerebellum, cerebral cortex, and retina demonstrates large accumulations of yellow-emitting autofluorescent storage bodies.
Wang P, Henthorn PS, Galban E, Lin G, Takedai T, Casal M. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene. J Vet Intern Med. 2018 Jan;32(1):340-347. doi: 10.1111/jvim.14862. Epub 2017 Nov 6. PMID: 29106755; PMCID: PMC5787214.
Kolicheski A, Johnson GS, Villani NA, O'Brien DP, Mhlanga-Mutangadura T, Wenger DA, Mikoloski K, Eagleson JS, Taylor JF, Schnabel RD, Katz ML. GM2 Gangliosidosis in Shiba Inu Dogs with an In-Frame Deletion in HEXB. J Vet Intern Med. 2017 Sep;31(5):1520-1526. doi: 10.1111/jvim.14794. Epub 2017 Aug 20. PMID: 28833537; PMCID: PMC5598891.